MIG 400 is an anti-inflammatory and analgesic preparation (non-steroidal anti-inflammatory preparation, NSAID) that lowers fever. It is recommended for use in pain of mild and moderate intensity, e.g. dysmenorrhea, post-traumatic pain, headache, toothache, muscle pain, neuralgia and for the treatment of fever. It is intended for children over 6 years of age, adolescents and adults.
MIG 400 is a preparation that contains ibuprofen as an active ingredient. One film-coated tablet contains 400 mg of ibuprofen. Ibuprofen is an organic chemical compound that belongs to the group of non-steroidal anti-inflammatory preparations (NSAIDs). It is a propionic acid derivative with anti-inflammatory, pain-relieving and antipyretic properties. The mechanism of its action is based on the inhibition of prostaglandin synthesis. Ibuprofen also reduces inflammation-related swelling and inhibits ADP and collagen-induced platelet aggregation. Its analgesic effect starts after approximately 30 minutes and lasts for 4 to 6 hours. It is excreted in the urine in 60-90% in the form of metabolites and does not accumulate in the body.
The film-coated tablet contains 400 mg of ibuprofen, the tablet can be divided into two equal parts.
MIG 400 is a preparation intended for oral administration. Recommended dosage:
MIG 400 is contraindicated in the case of:
- hypersensitivity to the active substance ibuprofen or any of the excipients;
- bronchospasm, asthma, rhinitis or urticaria after taking acetylsalicylic acid or other non-steroidal anti-inflammatory preparations (NSAIDs) in the history of
- nonspecific hematopoietic disorder;
- active or recurrent gastric ulcer and / or duodenal ulcer or gastrointestinal haemorrhage (two or more separate episodes of proven ulceration or bleeding);
- gastrointestinal bleeding or perforation as a consequence of a history of NSAIDs taking;
- bleeding in the brain or other active bleeding;
- severe renal or hepatic insufficiency; - severe heart failure.
It should not be used in women in the third trimester of pregnancy; in children weighing less than 20 kg (6 years), as this dose is not appropriate for this age group due to the active substance content.
There are no reviews for this product.